{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:16:32Z","timestamp":1793070992740,"version":"4.5.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/ajg.2012.7","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T08:03:37Z","timestamp":1327997017000},"page":"691-697","source":"Crossref","is-referenced-by-count":41,"title":["Viral Hepatitis in the Elderly"],"prefix":"10.14309","volume":"107","author":[{"given":"Andres F","family":"Carrion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-11-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-009-0087-2","article-title":"The healthcare burden imposed by liver disease in aging baby boomers.","volume":"12","author":"Davis","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"R5-11-20210210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1532-5415.1997.tb01484.x","article-title":"Viral hepatitis in older adults.","volume":"45","author":"Marcus","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"R6-11-20210210","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1982.00340210079017","article-title":"The clinical course of acute hepatitis in the elderly patient.","volume":"142","author":"Goodson","year":"1982","journal-title":"Arch Intern Med"},{"key":"R7-11-20210210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.1840090222","article-title":"The effect of age upon liver volume and apparent liver blood flow in healthy man.","volume":"9","author":"Wynne","year":"1989","journal-title":"Hepatology"},{"key":"R8-11-20210210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.41.4.430","article-title":"Parenchymal liver disease in the elderly.","volume":"41","author":"James","year":"1997","journal-title":"Gut"},{"key":"R9-11-20210210","first-page":"526379","article-title":"Liver regeneration and aging: a current perspective.","volume":"2011","author":"Schmucker","year":"2011","journal-title":"Curr Gastroenterol Geriatr Res"},{"key":"R10-11-20210210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.surg.2011.05.004","article-title":"The influence of donor age on liver regeneration and hepatic progenitor cell populations.","volume":"150","author":"Ono","year":"2011","journal-title":"Surgery"},{"key":"R11-11-20210210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.294.2.194","article-title":"Incidence of hepatitis A in the United States in the era of vaccination.","volume":"294","author":"Wasley","year":"2005","journal-title":"JAMA"},{"key":"R13-11-20210210","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2005.03.060","article-title":"Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey.","volume":"23","author":"Bell","year":"2005","journal-title":"Vaccine"},{"key":"R14-11-20210210","first-page":"595","article-title":"A multistate, foodborne outbreak of hepatitis A.","volume":"340","author":"Hautlin","year":"1998","journal-title":"N Engl J Med"},{"key":"R15-11-20210210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007611-200295080-00010","article-title":"Hepatitis A epidemic in the elderly.","volume":"95","author":"Brown","year":"2002","journal-title":"South Med J"},{"key":"R16-11-20210210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004836-199406000-00015","article-title":"Liver disease in the elderly.","volume":"18","author":"MacMahon","year":"1994","journal-title":"J Clin Gastroenterol"},{"key":"R17-11-20210210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-128-2-199801150-00006","article-title":"Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States.","volume":"128","author":"Willner","year":"1998","journal-title":"Ann Intern Med"},{"key":"R18-11-20210210","first-page":"237","article-title":"Increasing age, an important adverse prognostic factor in hepatitis A virus infection.","volume":"22","author":"Forbes","year":"1998","journal-title":"J R Coll Physicians Lond"},{"key":"R19-11-20210210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","article-title":"Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.","volume":"13","author":"DAcremont","year":"2006","journal-title":"J Travel Med"},{"key":"R21-11-20210210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0889-8553(05)70195-3","article-title":"Liver disease in the elderly.","volume":"30","author":"Ragev","year":"2001","journal-title":"Gastroenterol Clin North Am"},{"key":"R22-11-20210210","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1089\/ars.2010.3228","article-title":"Aging and immune function: molecular mechanisms to interventions.","volume":"14","author":"Ponnappan","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"RR-7","key":"R23-11-20210210","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R24-11-20210210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tmaid.2005.10.002","article-title":"Hepatitis A vaccines and the elderly.","volume":"4","author":"Genton","year":"2006","journal-title":"Travel Med Infect Dis"},{"key":"R25-11-20210210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1056\/NEJMoa050855","article-title":"An outbreak of hepatitis A associated with green onions.","volume":"353","author":"Wheeler","year":"2005","journal-title":"N Engl J Med"},{"key":"R26-11-20210210","first-page":"565","article-title":"Foodborne transmission of hepatitis A-Massachussetts, 2001.","volume":"52","year":"2003","journal-title":"MMWR"},{"key":"R27-11-20210210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2105\/AJPH.89.1.14","article-title":"Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.","volume":"89","author":"McQuillan","year":"1999","journal-title":"Am J Public Health"},{"key":"R28-11-20210210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination.","volume":"202","author":"Wasley","year":"2010","journal-title":"J Infect Dis"},{"key":"R29-11-20210210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2893.2006.00787.x","article-title":"Chronic hepatitis B: current epidemiology in the Americas and implications for management.","volume":"13","author":"Gish","year":"2006","journal-title":"J Viral Hepat"},{"key":"R30-11-20210210","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/hep.1840180404","article-title":"High carrier rate after hepatitis B virus infection in the elderly.","volume":"18","author":"Kondo","year":"1993","journal-title":"Hepatology"},{"key":"R31-11-20210210","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hep.22884","article-title":"Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.","volume":"49","author":"Chen","year":"2009","journal-title":"Hepatology"},{"key":"R32-11-20210210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.gastro.2010.04.048","article-title":"Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.","volume":"139","author":"Liu","year":"2010","journal-title":"Gastroenterology"},{"key":"R33-11-20210210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/geronj\/40.4.415","article-title":"Different course of acute hepatitis B in elderly adults.","volume":"40","author":"Zauli","year":"1985","journal-title":"J Gerontol"},{"key":"R34-11-20210210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma.","volume":"347","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"key":"R35-11-20210210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/JCM.40.1.16-21.2002","article-title":"Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.","volume":"40","author":"Chu","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R36-11-20210210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/jhep.2003.50352","article-title":"Prevalence of HBV precorecore promoter variants in the United States.","volume":"38","author":"Chu","year":"2003","journal-title":"Hepatology"},{"key":"R37-11-20210210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastreonterology"},{"key":"R38-11-20210210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1478-3231.2007.01580.x","article-title":"Interferon and lamivudine vs. interferon for hepatitis B e antigen positive hepatitis B treatment: meta-analysis of randomized controlled trials.","volume":"27","author":"Rudin","year":"2007","journal-title":"Liver Int"},{"key":"R39-11-20210210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00535-007-2015-2","article-title":"Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection.","volume":"42","author":"Kawaoka","year":"2007","journal-title":"J Gastroenterol"},{"key":"R40-11-20210210","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00002512-200825100-00002","article-title":"Viral hepatitis in elderly haemodialysis patients.","volume":"25","author":"Girndt","year":"2008","journal-title":"Drugs Aging"},{"key":"R41-11-20210210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00004836-200402000-00008","article-title":"Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea?","volume":"38","author":"Song","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R42-11-20210210","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/1096-9071(200012)62:4<456::AID-JMV10>3.0.CO;2-3","article-title":"Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis.","volume":"62","author":"Sugauchi","year":"2000","journal-title":"J Med Virol"},{"key":"R43-11-20210210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0008-8749(87)90294-2","article-title":"Alterations in the human immune response to the hepatitis B vaccine among the elderly.","volume":"109","author":"Cook","year":"1987","journal-title":"Cell Immunol"},{"key":"R44-11-20210210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2006.03035.x","article-title":"Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R45-11-20210210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/A:1006736931381","article-title":"Hepatitis B immunization of healthy elderly adults: relationship between naive CD4 T cells and primary immune response and evaluation of GM-CSF as an adjuvant.","volume":"21","author":"Hess","year":"2001","journal-title":"J Clin Immunol"},{"key":"R46-11-20210210","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1053\/j.gastro.2010.01.042","article-title":"Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.","volume":"138","author":"Chen","year":"2010","journal-title":"Gastroenterology"},{"key":"R47-11-20210210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R48-11-20210210","first-page":"1","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"Hpatology"},{"key":"R49-11-20210210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MCG.0b013e3181dd558c","article-title":"HbsAG seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma screening.","volume":"45","author":"Kim","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R50-11-20210210","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/j.gastro.2008.07.008","article-title":"HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.","volume":"135","author":"Yuen","year":"2008","journal-title":"Gastroenterology"},{"key":"R52-11-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"R53-11-20210210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"R54-11-20210210","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","article-title":"Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.","volume":"37","author":"Cheng","year":"2003","journal-title":"Hepatology"},{"key":"R55-11-20210210","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"R56-11-20210210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"R57-11-20210210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cgh.2008.07.017","article-title":"Hepatitis C in the elderly: epidemiology, natural history, and treatment.","volume":"7","author":"Mindikoglu","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R58-11-20210210","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1572-0241.2006.00556.x","article-title":"Hepatitis C in 6,865 patients 65yr or older: a severe and neglected curable disease.","volume":"101","author":"Thabut","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R59-11-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/qjmed\/89.4.291","article-title":"Hepatitis C virus infection in the elderly.","volume":"89","author":"Brind","year":"1996","journal-title":"QJM"},{"key":"R60-11-20210210","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1532-5415.1999.tb05236.x","article-title":"Seroprevalence of viral hepatitis in an older nursing home population.","volume":"47","author":"Chien","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"R61-11-20210210","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10620-007-9926-x","article-title":"Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 study.","volume":"53","author":"Tsui","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R62-11-20210210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C.","volume":"34","author":"Ponyard","year":"2001","journal-title":"J Hepatol"},{"key":"R63-11-20210210","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2001-12-0192","article-title":"Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.","volume":"99","author":"Minola","year":"2002","journal-title":"Blood"},{"key":"R64-11-20210210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.dld.2005.12.014","article-title":"Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study.","volume":"38","author":"Monica","year":"2006","journal-title":"Dig Liver Dis"},{"key":"R65-11-20210210","first-page":"1","article-title":"2002. NIH Consens State Sci S","volume":"19","author":"NIH Consensus Statement on Management of Hepatitis","year":"2002","journal-title":"tatements"},{"key":"R66-11-20210210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.20984","article-title":"Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.","volume":"43","author":"Iwasaki","year":"2006","journal-title":"Hepatology"},{"key":"R67-11-20210210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1440-1746.2006.04773.x","article-title":"Efficacy of ribavirin plus interferon-alpha in patients aged or 60 years with chronic hepatitis C.","volume":"22","author":"Honda","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R68-11-20210210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.2006.00643_4.x","article-title":"Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C.","volume":"54","author":"Floreani","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"R69-11-20210210","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update.","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R70-11-20210210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection.","volume":"55","author":"Craxi","year":"2011","journal-title":"J Hepatol"},{"key":"R71-11-20210210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrgastro.2009.138","article-title":"Hepatitis C: should antiviral therapy be offered to elderly patients?","volume":"6","author":"Floreani","year":"2009","journal-title":"Nat Rev Gastreonterol Hepatol"},{"key":"R72-11-20210210","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection.","volume":"364","author":"Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"R73-11-20210210","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection.","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"R74-11-20210210","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection.","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"R75-11-20210210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J Infect Dis"},{"key":"R76-11-20210210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.40.1.117-122.2002","article-title":"Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries.","volume":"40","author":"Meng","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R77-11-20210210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0035-9203(95)90529-4","article-title":"Two years investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo).","volume":"89","author":"Corwin","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R78-11-20210210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jmv.1890450413","article-title":"Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union.","volume":"45","author":"Trautwein","year":"1995","journal-title":"J Med Virol"},{"key":"R79-11-20210210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/MEG.0b013e3282f5195a","article-title":"Autochtonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderely and patients with chronic liver disease.","volume":"20","author":"Dalton","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R80-11-20210210","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg20127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg20127","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg20127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201205000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:37:42Z","timestamp":1786541862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201205000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2012.7","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}